• Complex
  • Title
  • Keyword
  • Abstract
  • Scholars
  • Journal
  • ISSN
  • Conference
搜索

Author:

Zhao, Pengxiang (Zhao, Pengxiang.) | Ma, Jianmin (Ma, Jianmin.) | Shang, Lei (Shang, Lei.) | Mawulikplimi, Adzavon Yao (Mawulikplimi, Adzavon Yao.) | Wang, Xiaoyue (Wang, Xiaoyue.) | Wu, Yanan (Wu, Yanan.) | Xie, Fei (Xie, Fei.) | Chen, Danying (Chen, Danying.) | Yang, Linqi (Yang, Linqi.) | Li, Qinjian (Li, Qinjian.) | Ma, Xuemei (Ma, Xuemei.) (Scholars:马雪梅)

Indexed by:

Scopus SCIE

Abstract:

Increasing evidences suggested macrophage migration inhibitory factor (MIF) was important in biological activities of inflammatory disease, cancer genesis and the transition process from inflammation to tumor. In our study, we raised the missing link between MIF and pathogenesis of Idiopathic Orbital Inflammatory Pseudotumor (IOIP). IOIP samples were assigned for bio-plex measurement of 41 (human cytokines, chemokines and growth factors) and 17 cytokines (Th17 related cytokines) in plasma and tissue, respectively. MIF was the most elevated serological cytokine (IOIP = 30060+/-4785 pg/mL; Normal Donor = 1700+/-63 pg/mL). Microarray analysis for MIF receptor genes in tissue mRNA revealed that CD74 and CXCR4 were up-regulated comparing with CD44 and CXCR2. Moreover, the expression level of MIF and its receptors (CD74, CXCR4) were also confirmed in tissue proteins by Western Blotting and immunofluorescence. We further found that the MIF downstream AKT signaling pathway was activated, targeting at phosphorylated-AKT, p53, bcl-2, p65, and p50 monomers. Analysis of the Single nucleotide polymorphism test revealed that MIF contributed at the genetic level, where MIF-173C and MIF-794 CATT7 alleles were possibly dangerous factors, while MIF-794 CATT6 allele may be a protective factor. This explained the high expression degree of MIF in affective tissue and plasma at the gene level. Considering the massive functions of MIF, we believe that during IOIP pathogenesis, this mighty cytokine could be playing an important role in IOIP disease development and maintenance.

Keyword:

MIF IOIP pathogenesis inflammation tumorigenesis

Author Community:

  • [ 1 ] [Zhao, Pengxiang]Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China
  • [ 2 ] [Shang, Lei]Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China
  • [ 3 ] [Mawulikplimi, Adzavon Yao]Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China
  • [ 4 ] [Wang, Xiaoyue]Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China
  • [ 5 ] [Wu, Yanan]Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China
  • [ 6 ] [Xie, Fei]Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China
  • [ 7 ] [Yang, Linqi]Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China
  • [ 8 ] [Li, Qinjian]Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China
  • [ 9 ] [Ma, Xuemei]Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China
  • [ 10 ] [Ma, Jianmin]Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Vis Sci Key Lab, Beijing 100730, Peoples R China
  • [ 11 ] [Chen, Danying]Capital Med Univ, Beijing Ditan Hosp, Beijing 100015, Peoples R China

Reprint Author's Address:

  • [Zhao, Pengxiang]Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China

Show more details

Related Keywords:

Source :

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY

ISSN: 1936-2625

Year: 2016

Issue: 7

Volume: 9

Page: 6659-6671

1 . 4 0 0

JCR@2022

ESI Discipline: CLINICAL MEDICINE;

ESI HC Threshold:203

CAS Journal Grade:4

Cited Count:

WoS CC Cited Count: 0

SCOPUS Cited Count:

ESI Highly Cited Papers on the List: 0 Unfold All

WanFang Cited Count:

Chinese Cited Count:

30 Days PV: 10

Online/Total:488/10598965
Address:BJUT Library(100 Pingleyuan,Chaoyang District,Beijing 100124, China Post Code:100124) Contact Us:010-67392185
Copyright:BJUT Library Technical Support:Beijing Aegean Software Co., Ltd.